Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

OXBROXBRIDGE RE HOLDINGS Ltd

Nasdaq · CIK 0001584831
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC6331 Fire, Marine & Casualty Insurance
FY end1231
XBRL facts371

Identity from submissions API

NameOXBRIDGE RE HOLDINGS Ltd
CIK0001584831
TickersOXBR, OXBRW
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC6331 Fire, Marine & Casualty Insurance
EIN981150254
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone345-749-7570
Website—
Investor website—
Owner org02 Finance
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
SUITE 201, 42 EDWARD STREET
P.O. BOX 469
GEORGETOWN
E9
KY1-9006
Cayman Islands
Mailing address
SUITE 201, 42 EDWARD STREET
P.O. BOX 469
GEORGETOWN
E9
KY1-9006
Cayman Islands

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

403 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-09 8-K 8-K 2.02,9.01 0001493152-26-050712 001-36346 261535798 34 379627 1 1
2026-11-09 10-Q 10-Q 0001493152-26-050711 001-36346 261535787 34 6101211 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001493152-26-037792 001-36346 261273771 34 426980 1 1
2026-08-13 10-Q 10-Q 0001493152-26-037784 001-36346 261273683 34 5515720 1 1
2026-06-22 424B5 424B5 0001493152-26-029639 333-287186 261108157 33 702763
2026-06-22 8-K 8-K 1.01,9.01 0001493152-26-029634 001-36346 261108132 34 898049 1 1
2026-06-16 8-K 8-K 5.07 0001493152-26-028929 001-36346 261095862 34 264457 1 1
2026-05-11 8-K 8-K 2.02,9.01 0001493152-26-022240 001-36346 26963562 34 371011 1 1
2026-05-11 10-Q 10-Q 0001493152-26-022220 001-36346 26963022 34 5205952 1 1
2026-04-28 ARS ARS 0001493152-26-019330 001-36346 26907560 34 1013396
2026-04-28 DEFA14A DEFA14A 0001493152-26-019324 001-36346 26907511 34 996462
2026-04-28 DEF 14A DEF 14A 0001493152-26-019323 001-36346 26907475 34 3462170 1 1
2026-04-17 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001538825-26-000002 005-88066 26870325 34 17965
2026-04-16 4 PRIMARY DOCUMENT 0001538825-26-000001 8315
2026-04-06 10-K/A 10-K/A 0001493152-26-015197 001-36346 26839320 34 1084228 1 1
2026-03-30 8-K 8-K 2.02,9.01 0001493152-26-013607 001-36346 26813665 34 370395 1 1
2026-03-30 10-K 10-K 0001493152-26-013603 001-36346 26813650 34 7766110 1 1
2026-02-13 8-K 8-K 1.01,2.03,9.01 0001493152-26-006760 001-36346 26634291 34 360732 1 1
2026-02-10 8-K 8-K 7.01,9.01 0001493152-26-005890 001-36346 26613497 34 266503 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001493152-25-021064 001-36346 251458134 34 363380 1 1
2025-11-06 10-Q 10-Q 0001493152-25-021063 001-36346 251458073 34 6412125 1 1
2025-09-19 4 PRIMARY DOCUMENT 0001538825-25-000012 7464
2025-09-16 8-K 8-K 8.01,9.01 0001493152-25-013740 001-36346 251317984 34 447640 1 1
2025-09-16 424B5 424B5 0001493152-25-013741 333-287186 251317981 33 15036
2025-09-04 8-K 8-K 3.02,5.02,5.03,5.07,9.01 0001641172-25-026604 001-36346 251294235 34 1486561 1 1
2025-08-29 4 PRIMARY DOCUMENT 0001538825-25-000011 8868
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003593 005-88066 251222163 34 10703
2025-08-14 10-Q 10-Q 0001641172-25-023960 001-36346 251218481 34 5730998 1 1
2025-08-14 8-K 8-K 2.02,9.01 0001641172-25-023959 001-36346 251218404 34 414720 1 1
2025-08-07 DEF 14A DEF 14A 0001641172-25-022627 001-36346 251195486 34 4086643 1 1
2025-07-28 PRE 14A PRE 14A 0001641172-25-021161 001-36346 251155578 34 3615202 1 1
2025-07-24 4 PRIMARY DOCUMENT 0001538825-25-000008 10383
2025-07-18 4 PRIMARY DOCUMENT 0001538825-25-000007 8254
2025-07-16 4 PRIMARY DOCUMENT 0001538825-25-000006 7353
2025-07-11 4 PRIMARY DOCUMENT 0001538825-25-000004 11686
2025-07-11 4/A PRIMARY DOCUMENT 0001538825-25-000003 4769
2025-07-10 8-K 8-K 1.01,9.01 0001641172-25-018541 001-36346 251114994 34 787456 1 1
2025-07-10 424B5 424B5 0001641172-25-018473 333-287186 251114428 33 603945
2025-07-08 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001538825-25-000002 005-88066 251109895 34 19503
2025-07-07 4 PRIMARY DOCUMENT 0001538825-25-000001 9845
2025-06-16 UPLOAD filename1.pdf 0000000000-25-006283 001-36346 39733
2025-05-27 4 xslF345X05/form4.xml 0000897069-25-001038 16062
2025-05-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001658 333-287186 25966051 33 1787
2025-05-19 4 xslF345X05/form4.xml 0000897069-25-001008 12017
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002247 005-88066 25951920 34 10636
2025-05-15 CORRESP filename1.htm 0001641172-25-010652 11479
2025-05-15 S-3/A S-3/A 0001641172-25-010649 333-287186 25950607 33 479822
2025-05-15 UPLOAD filename1.pdf 0000000000-25-005189 333-287186 40149
2025-05-14 8-K 8-K 5.07 0001641172-25-010031 001-36346 25941911 34 282908 1 1
2025-05-12 8-K 8-K 2.02,9.01 0001641172-25-009693 001-36346 25935085 34 351863 1 1
2025-05-12 S-3 S-3 0001641172-25-009665 333-287186 25934773 33 652473
2025-05-12 10-Q FORM 10-Q 0001641172-25-009673 001-36346 25934729 34 4589911 1 1
2025-05-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001456 333-286787 25923601 33 1787
2025-05-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001455 333-286786 25923600 33 1787
2025-05-05 CORRESP filename1.htm 0001641172-25-008665 17493
2025-05-05 CORRESP filename1.htm 0001641172-25-008663 12027
2025-05-05 CORRESP filename1.htm 0001641172-25-008661 11596
2025-05-05 UPLOAD filename1.pdf 0000000000-25-004714 333-286786 40188
2025-05-05 UPLOAD filename1.pdf 0000000000-25-004713 333-286787 40188
2025-04-25 S-3 forms-3.htm 0001641172-25-006293 333-286787 25875325 33 582802
2025-04-25 S-3 forms-3.htm 0001641172-25-006292 333-286786 25875324 33 625981
2025-04-01 UPLOAD filename1.pdf 0000000000-25-003481 001-36346 40912
2025-03-26 DEFA14A formdefa14a.htm 0001641172-25-000744 001-36346 25773154 34 1054171
2025-03-26 ARS formars.pdf 0001641172-25-000740 001-36346 25773123 34 1242895
2025-03-26 DEF 14A formdef14a.htm 0001641172-25-000739 001-36346 25773108 34 2915908 1 1
2025-03-26 8-K form8-k.htm 2.02,9.01 0001641172-25-000738 001-36346 25773088 34 446721 1 1
2025-03-26 10-K form10-k.htm 0001641172-25-000736 001-36346 25773070 34 7730295 1 1
2025-02-27 8-K form8-k.htm 7.01,9.01 0001493152-25-008464 001-36346 25673310 34 273578 1 1
2025-02-26 D xslFormDX01/primary_doc.xml 06c 0001493152-25-008343 021-539310 25669817 33 9861
2025-02-26 8-K form8-k.htm 1.01,3.02,9.01 0001493152-25-008296 001-36346 25666540 34 1163719 1 1
2025-02-26 424B5 form424b5.htm 0001493152-25-008248 333-262590 25666048 33 501707
2025-02-20 4 xslF345X05/form4.xml 0000897069-25-000339 4531
2025-02-20 4 xslF345X05/form4.xml 0000897069-25-000337 4564
2025-02-20 4 xslF345X05/form4.xml 0000897069-25-000335 4557
2025-02-20 4 xslF345X05/form4.xml 0000897069-25-000333 17402
2025-02-20 4 xslF345X05/form4.xml 0000897069-25-000331 14957
2025-01-13 8-K form8-k.htm 7.01,9.01 0001493152-25-001868 001-36346 25524870 34 282108 1 1
2025-01-07 8-K form8-k.htm 7.01 0001493152-25-001117 001-36346 25513490 34 267044 1 1
2024-11-13 8-K form8-k.htm 2.02,9.01 0001493152-24-045144 001-36346 241454771 34 556944 1 1
2024-11-13 10-Q form10-q.htm 0001493152-24-045109 001-36346 241453870 34 5355204 1 1
2024-10-18 4 PRIMARY DOCUMENT 0001538825-24-000006 7478
2024-08-09 4 PRIMARY DOCUMENT 0001538825-24-000005 9906
2024-08-08 8-K form8-k.htm 2.02,9.01 0001493152-24-030755 001-36346 241188206 34 655904 1 1
2024-08-08 10-Q form10-q.htm 0001493152-24-030747 001-36346 241188045 34 6233638 1 1
2024-08-07 4 PRIMARY DOCUMENT 0001538825-24-000004 9705
2024-08-01 4 PRIMARY DOCUMENT 0001538825-24-000003 9905
2024-07-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001538825-24-000002 005-88066 241157314 34 22519
2024-07-30 4 PRIMARY DOCUMENT 0001538825-24-000001 14980
2024-07-12 8-K form8-k.htm 3.02,9.01 0001493152-24-027057 001-36346 241113219 34 265332 1 1
2024-06-17 8-K form8-k.htm 5.07 0001493152-24-024100 001-36346 241048210 34 280836 1 1
2024-06-10 8-K form8-k.htm 7.01,9.01 0001493152-24-023274 001-36346 241031499 34 302889 1 1
2024-05-09 8-K form8-k.htm 2.02,9.01 0001493152-24-018421 001-36346 24930329 34 340125 1 1
2024-05-09 10-Q form10-q.htm 0001493152-24-018419 001-36346 24930313 34 4730089 1 1
2024-04-29 ARS ars.pdf 0001493152-24-016971 001-36346 24890928 34 988659
2024-04-29 DEFA14A formdefa14a.htm 0001493152-24-016969 001-36346 24890881 34 850200
2024-04-29 DEF 14A formdef14a.htm 0001493152-24-016960 001-36346 24890739 34 2026674
2024-04-17 4/A xslF345X05/ownership.xml 0001493152-24-015072 12555
2024-04-17 4/A xslF345X05/ownership.xml 0001493152-24-015070 14998
2024-04-16 4 xslF345X05/ownership.xml 0001493152-24-014905 12478
2024-04-16 4 xslF345X05/ownership.xml 0001493152-24-014906 4898
2024-04-16 4 xslF345X05/ownership.xml 0001493152-24-014907 4912
2024-04-16 4 xslF345X05/ownership.xml 0001493152-24-014904 14921
2024-04-16 4 xslF345X05/ownership.xml 0001493152-24-014908 4933
2024-03-28 8-K form8-k.htm 7.01,9.01 0001493152-24-011733 001-36346 24798786 34 271886 1 1
2024-03-27 8-K form8-k.htm 1.01,3.02,5.02,9.01 0001493152-24-011505 001-36346 24790947 34 603955 1 1
2024-03-26 8-K form8-k.htm 2.02,9.01 0001493152-24-011316 001-36346 24784140 34 365711 1 1
2024-03-26 10-K form10-k.htm 0001493152-24-011313 001-36346 24784067 34 7765126 1 1
2024-03-18 8-K form8-k.htm 7.01,9.01 0001493152-24-010215 001-36346 24757045 34 275246 1 1
2024-02-02 8-K form8-k.htm 3.03,7.01,9.01 0001493152-24-004739 001-36346 24591083 34 434407 1 1
2024-01-23 8-K form8-k.htm 7.01,9.01 0001493152-24-003384 001-36346 24550573 34 9945956 1 1
2024-01-03 UPLOAD filename1.pdf 0000000000-24-000086 001-36346 44281
2023-11-14 8-K form8-k.htm 2.02,9.01 0001493152-23-041110 001-36346 231406374 34 366107 1 1
2023-11-14 10-Q form10-q.htm 0001493152-23-041028 001-36346 231405656 34 5161382 1 1
2023-10-02 4 xslF345X05/form4.xml 0000897069-23-001411 14842
2023-09-22 4 PRIMARY DOCUMENT 0001538825-23-000004 7432
2023-09-12 4 PRIMARY DOCUMENT 0001538825-23-000003 11191
2023-08-14 10-Q form10-q.htm 0001493152-23-028394 001-36346 231169723 34 5046240 1 1
2023-08-14 8-K form8-k.htm 2.02,9.01 0001493152-23-028385 001-36346 231169575 34 360511 1 1
2023-07-31 SC 13D SC 13D 0001104659-23-085821 005-88066 231127449 34 196860
2023-07-31 3 OWNERSHIP DOCUMENT 0001104659-23-085817 10508
2023-06-28 8-K form8-k.htm 3.02,7.01,9.01 0001493152-23-022690 001-36346 231049336 34 328927 1 1
2023-06-05 8-K form8-k.htm 7.01,9.01 0001493152-23-020109 001-36346 23992474 34 8204220 1 1
2023-06-02 8-K form8-k.htm 5.07 0001493152-23-019852 001-36346 23986019 34 285966 1 1
2023-05-12 8-K form8-k.htm 2.02,9.01 0001493152-23-016652 001-36346 23916095 34 339773 1 1
2023-05-12 10-Q form10-q.htm 0001493152-23-016649 001-36346 23916065 34 4425674 1 1
2023-05-01 DEF 14A formdef14a.htm 0001493152-23-014954 001-36346 23873387 34 1784952
2023-03-30 10-K form10-k.htm 0001493152-23-009809 001-36346 23781503 34 7452163 1 1
2023-03-30 8-K form8-k.htm 2.02,9.01 0001493152-23-009728 001-36346 23780536 34 388873 1 1
2023-03-27 8-K form8-k.htm 7.01,9.01 0001493152-23-009010 001-36346 23761468 34 307632 1 1
2023-01-13 8-K form8-k.htm 3.02,5.02,9.01 0001493152-23-001467 001-36346 23529602 34 884180 1 1
2023-01-11 4 FORM 4 0001567619-23-000833 4764
2023-01-11 4 FORM 4 0001567619-23-000831 12372
2023-01-11 4 FORM 4 0001567619-23-000828 16705
2023-01-11 4 FORM 4 0001567619-23-000826 4736
2023-01-11 4 FORM 4 0001567619-23-000824 14820
2023-01-11 3 FORM 3 0001567619-23-000817 9623
2022-11-21 3 FORM 3 0001567619-22-020700 3124
2022-11-17 8-K form8-k.htm 5.02 0001493152-22-032737 001-36346 221397361 34 260845 1 1
2022-11-14 8-K form8-k.htm 2.02,9.01 0001493152-22-032173 001-36346 221386921 34 348715 1 1
2022-11-14 10-Q form10-q.htm 0001493152-22-031975 001-36346 221384845 34 5579557 1 1
2022-09-30 8-K form8-k.htm 1.01,8.01,9.01 0001493152-22-027309 001-36346 221285044 34 737035 1 1
2022-09-30 424B5 form424b5.htm 0001493152-22-027308 333-262590 221285028 33 433769
2022-09-06 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001493152-22-024870,2022-09-06 9999999995-22-002592 333-262590 221229830 33 1809
2022-09-01 POS AM formposam.htm 0001493152-22-024870 333-262590 221222316 33 372373
2022-08-15 8-K form8-k.htm 2.02,9.01 0001493152-22-023053 001-36346 221167556 34 352803 1 1
2022-08-15 10-Q form10-q.htm 0001493152-22-022900 001-36346 221165874 34 4347641 1 1
2022-06-09 SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0001829126-22-013263 005-88066 221006302 34 67404
2022-06-06 8-K form8-k.htm 5.07 0001493152-22-015983 001-36346 22998095 34 265879 1 1
2022-05-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-12 17:00:00 9999999995-22-001433 333-262590 22920039 33 1795
2022-05-12 10-Q FORM 10-Q 0001654954-22-006595 001-36346 22917682 34 4035529 1 1
2022-05-12 8-K FORM 8-K 2.02,9.01 0001654954-22-006596 001-36346 22917674 34 242840 1 1
2022-05-11 CORRESP filename1.htm 0001654954-22-006457 9305
2022-05-09 S-3/A S-3/A 0001654954-22-006303 333-262590 22905464 33 68110
2022-05-05 10-K/A FORM 10-K/A 0001654954-22-005998 001-36346 22892854 34 628078 1 1
2022-05-03 DEFR14A DEFR 14A 0001654954-22-005864 001-36346 22888038 34 683106
2022-05-03 NT 10-K NT 10-K 0001654954-22-005768 001-36346 22884450 34 21342
2022-05-03 DEF 14A DEF 14A 0001654954-22-005762 001-36346 22883772 34 655293
2022-04-04 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0001829126-22-007549 005-88066 22803378 34 118716
2022-04-01 4 FORM 4 0001567619-22-007878 10215
2022-04-01 4 FORM 4 0001567619-22-007875 8898
2022-03-31 8-K FORM-8K 3.02,5.02 0001654954-22-004351 001-36346 22794196 34 150133 1 1
2022-03-30 8-K FORM 8-K 2.02,9.01 0001654954-22-004188 001-36346 22787957 34 319087 1 1
2022-03-30 10-K FORM 10-K 0001654954-22-004186 001-36346 22787940 34 6424261 1 1
2022-02-14 UPLOAD filename1.pdf 0000000000-22-001748 40236
2022-02-08 S-3 FORM S-3 0001654954-22-001300 333-262590 22602616 33 389428
2021-12-13 8-K FORM 8-K 3.01 0001568276-21-002764 001-36346 211488647 34 164870 1 1
2021-11-30 4 FORM 4 0001567619-21-021268 5050
2021-11-30 3 FORM 3 0001567619-21-021266 3113
2021-11-19 8-K FORM 8-K 3.02,5.02 0001654954-21-012434 001-36346 211425862 34 168156 1 1
2021-11-12 8-K FORM 8-K 2.02,9.01 0001654954-21-012097 001-36346 211404674 34 319966 1 1
2021-11-12 10-Q PRIMARY DOCUMENT 0001654954-21-012095 001-36346 211404648 34 4303858 1 1
2021-08-16 10-Q PRIMARY DOCUMENT 0001654954-21-009072 001-36346 211178120 34 3683725 1 1
2021-08-16 8-K PRIMARY DOCUMENT 2.02,9.01 0001654954-21-009063 001-36346 211177769 34 220274
2021-08-16 8-K CURRENT REPORT 1.01,9.01 0001654954-21-009058 001-36346 211177676 34 33179
2021-07-19 8-K CURRENT REPORT 7.01,9.01 0001654954-21-008032 001-36346 211096889 34 61330
2021-07-13 SC 13D THE SCHEDULE 13D 0000921895-21-001854 005-88066 211088060 34 434210
2021-07-06 8-K CURRENT REPORT 5.02 0001654954-21-007665 001-36346 211075204 34 22893
2021-06-02 8-K FORM 8-K 5.07 0001654954-21-006527 001-36346 21989152 34 35375
2021-05-14 10-Q PRIMARY DOCUMENT 0001654954-21-005700 001-36346 21924555 34 2682897 1
2021-05-14 8-K CURRENT REPORT 2.02,9.01 0001654954-21-005697 001-36346 21924430 34 173554
2021-04-30 DEF 14A DEF 14A 0001654954-21-004947 001-36346 21879119 34 807040
2021-04-16 4 FORM 4 0001567619-21-008179 8199
2021-04-13 4 FORM 4 0001567619-21-007959 10073
2021-04-13 4 FORM 4 0001567619-21-007957 12362
2021-04-13 4 FORM 4 0001567619-21-007955 14739
2021-04-13 4 FORM 4 0001567619-21-007952 8756
2021-03-30 8-K FORM 8-K 2.02,9.01 0001654954-21-003526 001-36346 21786989 34 230514
2021-03-29 10-K ANNUAL REPORT 0001654954-21-003408 001-36346 21781769 34 6216065 1
2021-03-08 8-K CURRENT REPORT 5.02,9.01 0001654954-21-002431 001-36346 21720494 34 28762
2021-02-02 SC 13G/A cmw250.htm 0000897069-21-000035 005-88066 21579369 34 43551
2020-11-10 8-K CURRENT REPORT 2.02,9.01 0001654954-20-012117 001-36346 201301221 34 197820
2020-11-10 10-Q QUARTERLY REPORT 0001654954-20-012114 001-36346 201301125 34 3548646 1
2020-10-06 SC 13D/A SC 13D/A 0001104659-20-112735 005-88066 201227491 34 105098
2020-09-30 4 FORM 4 0001567619-20-017223 8527
2020-09-29 4 OWNERSHIP DOCUMENT 0001104659-20-109925 8908
2020-08-14 SC 13G/A cmw226.htm 0000897069-20-000343 005-88066 201104717 34 48383
2020-08-10 8-K CURRENT REPORT 2.02,9.01 0001654954-20-008722 001-36346 201089579 34 217311
2020-08-10 10-Q QUARTERLY REPORT 0001654954-20-008714 001-36346 201089296 34 3194722 1
2020-06-22 SC 13D/A SC 13D/A 0001104659-20-075668 005-88066 20979496 34 150678
2020-06-22 4 FORM 4 0001567619-20-012478 8526
2020-06-18 8-K CURRENT REPORT 7.01 0001654954-20-006774 001-36346 20972512 34 29894
2020-06-10 4 FORM 4 0001567619-20-011956 7512
2020-05-20 8-K CURRENT REPORT 5.07 0001654954-20-005831 001-36346 20898126 34 31382
2020-05-14 10-Q QUARTERLY REPORT 0001654954-20-005483 001-36346 20878022 34 2895346 1
2020-05-14 8-K CURRENT REPORT 2.02,9.01 0001654954-20-005469 001-36346 20877642 34 174928
2020-05-05 8-K CURRENT REPORT 3.01,7.01 0001654954-20-004928 001-36346 20848734 34 34176
2020-04-24 DEFR14A DEFR14A 0001654954-20-004404 001-36346 20815142 34 507717
2020-04-24 DEF 14A PROXY STATEMENT 0001654954-20-004357 001-36346 20812209 34 505221
2020-03-23 8-K CURRENT REPORT 2.02,9.01 0001654954-20-002992 001-36346 20734971 34 249076
2020-03-23 10-K ANNUAL REPORT 0001654954-20-002991 001-36346 20734946 34 5091946 1
2020-02-20 8-K CURRENT REPORT 3.01 0001654954-20-001775 001-36346 20635024 34 29145
2020-02-13 SC 13G/A cmw187.htm 0000897069-20-000112 005-88066 20609830 34 49335
2019-12-06 8-K CURRENT REPORT 3.01,7.01 0001654954-19-013681 001-36346 191273100 34 33215
2019-11-04 10-Q QUARTERLY REPORT 0001654954-19-012334 001-36346 191189800 34 3754706 1
2019-11-04 8-K CURRENT REPORT 2.02,9.01 0001654954-19-012333 001-36346 191189770 34 249871
2019-10-08 4 FORM 4 0001567619-19-019350 11156
2019-10-08 4 FORM 4 0001567619-19-019348 13849
2019-10-02 4 FORM 4 0001567619-19-019087 6243
2019-08-01 8-K CURRENT REPORT 2.02,9.01 0001654954-19-008747 001-36346 19992652 34 248274
2019-08-01 10-Q QUARTERLY REPORT 0001654954-19-008742 001-36346 19992564 34 3698330 1
2019-05-16 8-K CURRENT REPORT 5.07 0001654954-19-006156 001-36346 19830479 34 50659
2019-05-15 8-K/A FORM 8-K/A 2.02,9.01 0001654954-19-006008 001-36346 19825809 34 185762
2019-05-14 8-K CURRENT REPORT 2.02,9.01 0001654954-19-005907 001-36346 19822776 34 169080
2019-05-14 10-Q QUARTERLY REPORT 0001654954-19-005905 001-36346 19822713 34 3750552 1
2019-05-02 4 OWNERSHIP DOCUMENT 0001144204-19-023196 7143
2019-04-17 DEFR14A AMENDMENT NO. 2 TO DEFINITIVE PROXY STATEMENT 0001654954-19-004526 001-36346 19753111 34 628434
2019-04-16 DEFR14A DEFR14A 0001654954-19-004436 001-36346 19750076 34 629059
2019-04-15 424B3 424B3 0001654954-19-004407 333-193577 19749118 33 565481
2019-04-15 DEF 14A PROXY STATEMENT 0001654954-19-004405 001-36346 19749106 34 561560
2019-04-01 4 OWNERSHIP DOCUMENT 0001144204-19-017491 11116
2019-03-21 424B3 PROSPECTUS SUPPLEMENT 0001654954-19-003042 333-193577 19697144 33 37421
2019-03-21 8-K CURRENT REPORT 5.02,9.01 0001654954-19-003041 001-36346 19697126 34 29904
2019-03-19 8-K CURRENT REPORT 2.02,9.01 0001654954-19-002952 001-36346 19691703 34 261360
2019-03-19 424B3 PROSPECTUS SUPPLEMENT 0001654954-19-002950 333-193577 19691648 33 1959326
2019-03-19 10-K FORM 10-K 0001654954-19-002948 001-36346 19691601 34 5818849 1
2019-02-19 4 OWNERSHIP DOCUMENT 0001144204-19-008961 56032
2019-02-14 SC 13D SC 13D 0001144204-19-008130 005-88066 19606753 34 127619
2019-01-18 SC 13G/A cmw40.htm 0000897069-19-000040 005-88066 19532777 34 36863
2018-12-07 SC 13D/A SC 13D/A 0001144204-18-063635 005-88066 181224169 34 117450
2018-12-07 4 FORM 4 0001567619-18-007496 7998
2018-12-07 4 FORM 4 0001567619-18-007460 10142
2018-12-04 4 FORM 4 0001567619-18-007311 8753
2018-11-26 4 FORM 4 0001567619-18-006973 8749
2018-11-19 8-K CURRENT REPORT 3.03,7.01,9.01 0001654954-18-012983 001-36346 181193394 34 175859
2018-11-13 8-K CURRENT REPORT 2.02,9.01 0001654954-18-012528 001-36346 181178123 34 243029
2018-11-13 424B3 PROSPECTUS SUPPLEMENT NO. 37 0001654954-18-012524 333-193577 181178067 33 1430251
2018-11-13 10-Q QUARTERLY REPORT 0001654954-18-012513 001-36346 181177867 34 4870388 1
2018-08-14 8-K CURRENT REPORT 2.02,9.01 0001654954-18-009125 001-36346 181017758 34 261315
2018-08-14 424B3 424B3 0001654954-18-009118 333-193577 181017720 33 1468116
2018-08-14 10-Q QUARTERLY REPORT 0001654954-18-009105 001-36346 181017486 34 5417603 1
2018-05-16 424B3 PROSPECTUS SUPPLEMENT NO. 35 0001654954-18-005530 333-193577 18840002 33 47111
2018-05-16 8-K PRIMARY DOCUMENT 5.07 0001654954-18-005529 001-36346 18839983 34 39264
2018-05-15 8-K CURRENT REPORT 2.02,9.01 0001654954-18-005422 001-36346 18836479 34 178936
2018-05-15 424B3 PROSPECTUS SUPPLEMENT NO. 34 0001654954-18-005419 333-193577 18836418 33 1157785
2018-05-15 10-Q QUARTERLY REPORT 0001654954-18-005416 001-36346 18836240 34 4113061 1
2018-04-17 424B3 PROSPECTUS SUPPLEMENT NO. 33 0001654954-18-003986 333-193577 18757790 33 477231
2018-04-17 DEF 14A DEFINITIVE PROXY STATEMENT 0001654954-18-003984 001-36346 18757786 34 470255
2018-03-13 8-K CURRENT REPORT 2.02,9.01 0001654954-18-002497 001-36346 18686531 34 215698
2018-03-13 424B3 PROSPECTUS SUPPLEMENT NO. 32 0001654954-18-002493 333-193577 18686521 33 1856524
2018-03-13 10-K ANNUAL REPORT 0001654954-18-002491 001-36346 18686473 34 5787273 1
2018-02-06 SC 13G/A cg1028.htm 0000897069-18-000092 005-88066 18577973 34 43306
2018-01-04 424B3 PROSPECTUS SUPPLEMENT NO. 31 0001654954-18-000110 333-193577 18511123 33 33552
2018-01-04 8-K CURRENT REPORT 5.02 0001654954-18-000108 001-36346 18511112 34 25778
2017-11-28 SC 13G cg997.htm 0000897069-17-000568 005-88066 171223925 34 44735
2017-11-14 8-K CURRENT REPORT 2.02,8.01,9.01 0001654954-17-010625 001-36346 171201584 34 222790
2017-11-14 424B3 PROSPECTUS SUPPLEMENT NO. 30 0001654954-17-010619 333-193577 171201471 33 1497787
2017-11-14 10-Q QUARTERLY REPORT 0001654954-17-010617 001-36346 171201425 34 4746287 1
2017-09-28 424B3 PROSPECTUS SUPPLEMENT NO. 29 0001654954-17-008912 333-193577 171107947 33 38606
2017-09-28 8-K CURRENT REPORT 8.01 0001654954-17-008911 001-36346 171107918 34 30748
2017-08-14 424B3 PROSPECTUS SUPPLEMENT NO. 28 0001654954-17-007566 333-193577 171030882 33 1516599
2017-08-14 8-K CURRENT REPORT 2.02,9.01 0001654954-17-007565 001-36346 171030854 34 245099
2017-08-14 10-Q QUARTERLY REPORT 0001654954-17-007559 001-36346 171030705 34 5794389 1
2017-05-25 424B3 PROSPECTUS SUPPLEMENT NO. 27 0001654954-17-005109 333-193577 17869975 33 33947
2017-05-25 8-K CURRENT REPORT 5.02 0001654954-17-005108 001-36346 17869954 34 26074
2017-05-17 8-K CURRENT REPORT 5.07 0001654954-17-004881 001-36346 17851402 34 58808
2017-05-17 424B3 PROSPECTUS SUPPLEMENT NO. 26 0001654954-17-004879 333-193577 17851382 33 66778
2017-05-15 424B3 PROSPECTUS SUPPLEMENT NO. 25 0001654954-17-004750 333-193577 17844405 33 1307340
2017-05-15 8-K CURRENT REPORT 2.02,9.01 0001654954-17-004743 001-36346 17844201 34 169204
2017-05-15 10-Q QUARTERLY REPORT 0001654954-17-004741 001-36346 17844133 34 4687549 1
2017-04-25 424B3 PROSPECTUS SUPPLEMENT 0001654954-17-003599 333-193577 17779424 33 727608
2017-04-25 DEF 14A DEFINITIVE PROXY STATEMENT 0001654954-17-003597 001-36346 17779416 34 637755
2017-04-24 3/A FORM 3/A 0001140361-17-016512 5137
2017-03-21 4 FORM 4 0001140361-17-012831 9765
2017-03-21 4 FORM 4 0001140361-17-012829 12454
2017-03-13 424B3 424B3 0001654954-17-001932 333-193577 17685377 33 1828505
2017-03-13 8-K CURRENT REPORT 2.02,9.01 0001654954-17-001931 001-36346 17685368 34 213910
2017-03-13 10-K ANNUAL REPORT 0001654954-17-001925 001-36346 17685224 34 6143495 1
2017-01-24 424B3 PROSPECTUS SUPPLEMENT NO 22 0001654954-17-000465 333-193577 17543774 33 37556
2017-01-24 8-K CURRENT REPORT 5.02,9.01 0001654954-17-000463 001-36346 17543754 34 30203
2016-11-14 8-K CURRENT REPORT 2.02,9.01 0001654954-16-004013 001-36346 161996460 34 222774
2016-11-14 424B3 PROSPECTUS SUPPLEMENT NO. 21 0001654954-16-003995 333-193577 161995765 33 1564023
2016-11-14 10-Q QUARTERLY REPORT 0001654954-16-003977 001-36346 161995252 34 6086904 1
2016-08-15 8-K CURRENT REPORT 2.02,9.01 0001654954-16-001603 001-36346 161832863 34 229670
2016-08-15 424B3 PROSPECTUS SUPPLEMENT NO. 20 0001654954-16-001601 333-193577 161832784 33 1432905
2016-08-15 10-Q QUARTERLY REPORT 0001654954-16-001599 001-36346 161832682 34 4753267 1
2016-06-13 4 FORM 4 0001140361-16-069626 10579
2016-06-13 4/A FORM 4/A 0001140361-16-069623 11982
2016-06-13 5/A FORM 5/A 0001140361-16-069621 20844
2016-06-08 4 FORM 4 0001140361-16-069181 5134
2016-06-08 4 FORM 4 0001140361-16-069167 4489
2016-06-02 424B3 PROSPECTUS SUPPLEMENT NO. 19 0001654954-16-000411 333-193577 161692888 33 32476
2016-06-02 8-K CURRENT REPORT 8.01 0001654954-16-000410 001-36346 161692860 34 24340
2016-05-25 424B3 PROSPECTUS SUPPLEMENT NO.18 0001654954-16-000378 333-193577 161674719 33 66495
2016-05-25 8-K CURRENT REPORT 5.07 0001654954-16-000377 001-36346 161674712 34 58813
2016-05-16 8-K CURRENT REPORT 2.02,9.01 0001654954-16-000326 001-36346 161653606 34 189822 1
2016-05-16 424B3 PROSPECTUS SUPPLEMENT NO. 17 0001354488-16-007487 333-193577 161653592 33 1203054
2016-05-16 10-Q QUARTERLY REPORT 0001654954-16-000325 001-36346 161653568 34 4200776 1
2016-04-14 424B3 424B3 0001654954-16-000249 333-193577 161570729 33 600684
2016-04-12 DEF 14A PROXY STATEMENT 0001654954-16-000236 001-36346 161567306 34 564047
2016-03-17 8-K CURRENT REPORT 2.02,9.01 0001654954-16-000185 001-36346 161512616 34 336473 1
2016-03-17 424B3 424B3 0001654954-16-000183 333-193577 161512571 33 1749711
2016-03-17 10-K ANNUAL REPORT 0001654954-16-000181 001-36346 161512554 34 10430593 1
2016-02-17 5/A FORM 5/A 0001140361-16-053589 8395
2016-02-16 5 FORM 5 0001140361-16-052593 8274
2016-02-16 5 FORM 5 0001140361-16-052590 12368
2016-02-02 424B3 PROSPECTUS SUPPLEMENT NO. 14 0001193125-16-447644 333-193577 161380979 33 20576
2016-02-02 8-K/A FORM 8-K AMENDMENT NO. 1 5.02,9.01 0001193125-16-447628 001-36346 161380850 34 16561
2016-01-20 424B3 PROSPECTUS SUPPLEMENT NO. 13 0001193125-16-433569 333-193577 161351066 33 20252
2016-01-20 8-K FORM 8-K 5.02,9.01 0001193125-16-433564 001-36346 161351035 34 16311
2015-11-12 8-K FORM 8-K 2.02,9.01 0001193125-15-374427 001-36346 151221150 34 81932
2015-11-12 424B3 PROSPECTUS SUPPLEMENT 0001193125-15-374342 333-193577 151221110 33 525190
2015-11-12 10-Q FORM 10Q 0001193125-15-373935 001-36346 151221062 34 4014796 1
2015-10-29 8-K FORM 8-K 5.07 0001193125-15-357276 001-36346 151182363 34 22610
2015-08-12 8-K 8-K 2.02,9.01 0001193125-15-288105 001-36346 151047178 34 89465
2015-08-12 424B3 PROSPECTUS SUPPLEMENT NO. 11 0001193125-15-288096 333-193577 151047126 33 642193
2015-08-12 10-Q FORM 10-Q 0001193125-15-288072 001-36346 151047025 34 4486867 1
2015-08-11 424B3 PROSPECTUS SUPPLEMENT 0001193125-15-286422 333-193577 151043982 33 25687
2015-08-11 8-K FORM 8-K 5.07 0001193125-15-286409 001-36346 151043931 34 21515
2015-07-20 424B3 PROSPECTUS SUPPLEMENT NO. 9 DATED JULY 20, 2015 0001193125-15-256994 333-193577 15996000 33 174782
2015-07-20 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-15-256982 001-36346 15995963 34 205525
2015-05-14 8-K FORM 8-K 2.02,9.01 0001193125-15-188033 001-36346 15863060 34 88738
2015-05-14 424B3 PROSPECTUS SUPPLEMENT 0001193125-15-187996 333-193577 15862895 33 418650
2015-05-14 10-Q FORM 10-Q 0001193125-15-187960 001-36346 15862759 34 4750623 1
2015-03-30 4 FORM 4 0001140361-15-013501 5234
2015-03-26 4 FORM 4 0001140361-15-013254 10073
2015-03-24 4 FORM 4 0001140361-15-013044 5269
2015-03-18 8-K FORM 8-K 2.02,9.01 0001193125-15-097076 001-36346 15710605 34 104959
2015-03-18 424B3 PROSPECTUS SUPPLEMENT NO. 7 0001193125-15-097049 333-193577 15710509 33 826370
2015-03-18 10-K FORM 10-K 0001193125-15-097032 001-36346 15710444 34 5556119 1
2015-01-28 424B3 PROSPECTUS SUPPLEMENT NO. 6 0001193125-15-022591 333-193577 15553167 33 1083988
2015-01-28 8-K FORM 8-K 5.02,9.01 0001193125-15-022588 001-36346 15553164 34 122454
2014-12-24 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-14-453326 001-36346 141308681 34 337916
2014-12-12 4 FORM 4 0001140361-14-045031 4531
2014-12-08 4 FORM 4 0001140361-14-044368 4648
2014-11-26 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-14-015951 001-36346 14008702 34 1382
2014-11-24 DEF 14A DEFINITIVE PROXY STATEMENT 0001193125-14-423437 001-36346 141246746 34 627840
2014-11-10 PRE 14A PRELIMINARY PROXY STATEMENT 0001193125-14-406200 001-36346 141209330 34 628396
2014-11-10 8-K FORM 8-K 2.02,9.01 0001193125-14-406179 001-36346 141209247 34 102883
2014-11-10 424B3 PROSPECTUS SUPPLEMENT 0001193125-14-406166 333-193577 141209183 33 477742
2014-11-10 10-Q FORM 10-Q 0001193125-14-406135 001-36346 141209098 34 3643178 1
2014-09-03 4 FORM 4 0001140361-14-034734 5126
2014-08-22 4 FORM 4 0001140361-14-033926 7249
2014-08-22 4 FORM 4 0001140361-14-033916 5709
2014-08-21 4 FORM 4 0001140361-14-033779 9123
2014-08-14 8-K FORM 8-K 2.02,9.01 0001193125-14-310160 001-36346 141042950 34 97072
2014-08-14 424B3 PROSPECTUS SUPPLEMENT NO 4 0001193125-14-310137 333-193577 141042840 33 275481
2014-08-14 10-Q FORM 10-Q 0001193125-14-310105 001-36346 141042659 34 1982897 1
2014-05-28 424B3 PROSPECTUS SUPPLEMENT NO. 3 0001193125-14-214575 333-193577 14872129 33 150109
2014-05-28 8-K FORM 8-K 8.01,9.01 0001193125-14-214567 001-36346 14872119 34 146229
2014-05-13 8-K FORM 8-K 2.02,9.01 0001193125-14-197137 001-36346 14837870 34 86762
2014-05-13 424B3 PROSPECTUS SUPPLEMENT 0001193125-14-197121 333-193577 14837793 33 221912
2014-05-13 10-Q FORM 10-Q 0001193125-14-196980 001-36346 14837312 34 1712494 1
2014-05-08 25 FORM 25 0001193125-14-189917 001-36346 14824846 34 11147
2014-05-06 424B3 PROSPECTUS SUPPLEMENT 0001193125-14-184618 333-193577 14816665 33 46305
2014-05-06 424B3 424(B)(3) 0001193125-14-183711 333-193577 14815416 33 5093
2014-05-06 8-K FORM 8-K 3.01,7.01,9.01 0001193125-14-183529 001-36346 14815309 34 42622
2014-04-24 4 FORM 4 0001140361-14-017425 7714
2014-04-17 4 FORM 4 0001140361-14-017008 7712
2014-04-16 4 FORM 4 0001140361-14-016877 7711
2014-04-16 4/A FORM 4/A 0001140361-14-016875 12405
2014-04-16 4/A FORM 4/A 0001140361-14-016873 8424
2014-04-11 4 FORM 4 0001140361-14-016486 11565
2014-04-03 SC 13D FORM SC 13D 0001144204-14-020480 005-88066 14741439 34 114083
2014-04-02 4 FORM 4 0001140361-14-015360 15402
2014-03-28 4 FORM 4 0001140361-14-014582 17723
2014-03-28 4 FORM 4 0001140361-14-014570 15028
2014-03-28 4 FORM 4 0001140361-14-014568 17737
2014-03-28 4 FORM 4 0001140361-14-014567 21930
2014-03-28 4 FORM 4 0001140361-14-014566 23481
2014-03-28 4 FORM 4 0001140361-14-014565 24017
2014-03-26 8-K FORM 8-K 7.01,9.01 0001193125-14-116742 001-36346 14719311 34 41490
2014-03-26 3 FORM 3 0001140361-14-014282 5914
2014-03-26 3 FORM 3 0001140361-14-014281 9231
2014-03-26 3 FORM 3 0001140361-14-014280 5452
2014-03-26 3 FORM 3 0001140361-14-014279 3602
2014-03-26 3 FORM 3 0001140361-14-014276 7861
2014-03-26 3 FORM 3 0001140361-14-014275 4758
2014-03-26 3 FORM 3 0001140361-14-014274 8922
2014-03-26 CERTNAS AUTO-GENERATED PAPER DOCUMENT 9999999997-14-004548 001-36346 14005878 34 1328
2014-03-21 424B3 424(B)(3) 0001193125-14-110034 333-193577 14709666 33 945349
2014-03-19 FWP FWP 0001193125-14-106637 333-193577 14704699 34 43017
2014-03-18 S-1MEF FORM S-1MEF 0001193125-14-103969 333-194648 14700426 33 63549
2014-03-11 8-A12B FORM 8-A 0001193125-14-093063 001-36346 14683185 34 14925
2014-02-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2014-02-28 16:00:00 9999999995-14-000559 333-193577 14658070 33 1721
2014-02-26 CORRESP filename1.htm 0001193125-14-069715 5376
2014-02-26 CORRESP filename1.htm 0001193125-14-069705 7331
2014-02-18 S-1/A FORM S-1 - AMENDMENT NO 1 0001193125-14-056682 333-193577 14621208 33 1486821
2014-02-11 UPLOAD filename1.pdf 0000000000-14-007267 168451
2014-01-29 F-N APPOINTMENT OF AN AGENT 0001193125-14-025972 333-193577 14556105 33 19800
2014-01-27 S-1 REGISTRATION STATEMENT 0001193125-14-022017 333-193577 14548735 33 3205038

Latest XBRL company facts

One latest value per concept from companyfacts (371 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 8.18M 2026-11-09 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
dei EntityPublicFloat Entity Public Float USD 11.65M 2025-06-30 2025 FY 10-K/A 2026-04-06 0001493152-26-015197
ecd AdjToCompAmt AdjToCompAmt USD 96,600 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001493152-26-019323
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 291,352 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001493152-26-019323
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 334,227 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001493152-26-019323
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 433,777 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001493152-26-019323
ecd PeoTotalCompAmt PeoTotalCompAmt USD 502,377 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001493152-26-019323
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 70.59 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001493152-26-019323
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 7.5 2014-02-28 2015 Q3 10-Q 2015-11-12 0001193125-15-373935
us-gaap AccountsPayableAndAccruedLiabilitiesFairValueDisclosure Accounts Payable and Accrued Liabilities, Fair Value Disclosure USD 329,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037784
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 322,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 216,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 1.07M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031975
us-gaap AccountsReceivableFairValueDisclosure Accounts Receivable, Fair Value Disclosure USD 177,000 2021-06-30 2021 Q2 10-Q 2021-08-16 0001654954-21-009072
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 0 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 130,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 38.65M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 37.34M 2025-03-31 2025 Q1 10-Q 2025-05-12 0001641172-25-009673
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 45,000 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037784
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 5.08M 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-17 0001654954-16-000181
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 98,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 451,250 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001654954-21-009072
us-gaap Assets Assets USD 19.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 19.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap AssumedPremiumsEarned Assumed Premiums Earned USD 314,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap AssumedPremiumsWritten Assumed Premiums Written USD 1.12M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-04 0001654954-19-012334
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 28,000 2016-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 37,000 2016-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 991,000 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax USD 136,000 2016-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax USD 538,000 2016-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap AvailableForSaleEquitySecuritiesAmortizedCostBasis Available-for-sale Equity Securities, Amortized Cost Basis USD 2.06M 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 993,000 2018-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2018-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 0 2018-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 991,000 2018-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax (Deprecated 2018-01-31) USD -3,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001654954-18-005416
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 30,000 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss USD 80,000 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 5.57M 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 50,000 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 2.40M 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 3.18M 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 0 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 0 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 2.97M 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 2.96M 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 USD 0 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 USD 0 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 0 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 0 2014-09-30 2014 Q3 10-Q 2014-11-10 0001193125-14-406135
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap AvailableForSaleSecuritiesEquitySecurities Available-for-sale Securities, Equity Securities USD 765,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 7,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year Segment 8 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap BenefitsLossesAndExpenses Benefits, Losses and Expenses USD 570,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001641172-25-009673
us-gaap Cash Cash USD 5.56M 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 4.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -1.91M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 3.62M 2023-03-31 2023 Q1 10-Q 2023-05-12 0001493152-23-016649
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 19.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 19.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -2,058 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 12.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 4.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CededPremiumsEarned Ceded Premiums Earned USD 60,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041028
us-gaap CededPremiumsWritten Ceded Premiums Written USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 7.5 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193125-14-310105
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 7.5 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022900
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 1 2013-06-30 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 215,000 2017-09-30 2017 Q3 10-Q 2017-11-14 0001654954-17-010617
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 8.23M 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-022900
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0.12 2015-08-07 2015 Q3 10-Q 2015-11-12 0001193125-15-373935
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 8.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 8.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 8.56M 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 118,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037784
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.00M 2026-02-11 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 107,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.251 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028394
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.16 2026-02-11 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD -1.94M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001493152-24-045109
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 417,000 2013-12-31 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap DeferredPolicyAcquisitionCostAmortizationExpense Deferred Policy Acquisition Costs, Amortization Expense USD 23,000 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-12 0001493152-23-016649
us-gaap DeferredPolicyAcquisitionCosts Deferred Policy Acquisition Cost USD 25,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap DeferredPolicyAcquisitionCostsNet Deferred Policy Acquisition Costs, Net (Deprecated 2014-01-31) USD 291,000 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193125-14-310105
us-gaap Depreciation Depreciation USD 2,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 400,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001654954-18-012513
us-gaap DividendAndInterestReceivable DividendAndInterestReceivable USD 13,000 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041028
us-gaap DividendsCash Dividends, Cash USD -1.71M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap DividendsCommonStock Dividends, Common Stock USD 2.09M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 2.10M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001654954-18-002491
us-gaap DueFromBanks Due from Banks USD 2.69M 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap DueFromRelatedParties Due from Related Parties USD 45,000 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009809
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 68,000 2021-03-31 2021 Q1 10-Q 2021-05-14 0001654954-21-005700
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 1.22 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.03 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 64,500 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 85,302 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 0 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 48,000 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009809
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 1 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-187960
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 113,000 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap EquitySecuritiesFvNiCost Equity Securities, FV-NI, Cost USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD 2,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap EquitySecuritiesFvNiRealizedGain Equity Securities, FV-NI, Realized Gain USD 27,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap EquitySecuritiesFvNiUnrealizedGainLoss Equity Securities, FV-NI, Unrealized Gain (Loss) USD -34,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041028
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 5.00M 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-196980
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0.08 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001654954-18-002491
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.48 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001654954-18-002491
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.017 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001654954-18-002491
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001654954-21-005700
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 329,000 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037784
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2021-06-30 2021 Q2 10-Q 2021-08-16 0001654954-21-009072
us-gaap ForeignReinsuranceTransactionsExpenseAdditionsToUnderwritingBalances ForeignReinsuranceTransactionsExpenseAdditionsToUnderwritingBalances USD 114,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -230,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap IncomeLossAttributableToNoncontrollingInterest Income (Loss) Attributable to Noncontrolling Interest, before Tax USD 94,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-04 0001654954-19-012334
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -59,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncomeLossFromSubsidiariesNetOfTax Income (Loss) from Subsidiaries, Net of Tax USD -658,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap IncomeLossIncludingPortionAttributableToNoncontrollingInterest Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax USD -43,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031975
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 26,000 2022-01-01 2022-03-31 2023 Q1 10-Q 2023-05-12 0001493152-23-016649
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.07M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-26 0001641172-25-000736
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 13,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-13 0001493152-24-045109
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap IncreaseDecreaseInDeferredPolicyAcquisitionCosts Increase (Decrease) in Deferred Policy Acquisition Costs USD -77,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -63,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD -30,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve USD 175,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001641172-25-023960
us-gaap IncreaseDecreaseInLossAndLossAdjustmentExpenseReserve Increase (Decrease) in Loss and Loss Adjustment Expense Reserve (Deprecated 2015-01-31) USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-187960
us-gaap IncreaseDecreaseInNotesReceivableRelatedParties Increase (Decrease) in Notes Receivable, Related Parties USD -177,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001654954-21-009072
us-gaap IncreaseDecreaseInOperatingAssets Increase (Decrease) in Operating Assets USD 155,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD 2,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 9,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInOperatingLiabilities Increase (Decrease) in Operating Liabilities USD 149,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap IncreaseDecreaseInOptionPremiumContractsPayable Increase (Decrease) in Option Premium Contracts Payable USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -948,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-26 0001641172-25-000736
us-gaap IncreaseDecreaseInPremiumsReceivable Increase (Decrease) in Premiums Receivable USD -564,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -45,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInReinsurancePayables Increase (Decrease) in Reinsurance Payables USD 73,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap IncreaseDecreaseInReinsuranceRecoverable Increase (Decrease) in Reinsurance Recoverable USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-13 0001654954-18-012513
us-gaap IncreaseDecreaseInRestrictedCashAndInvestments Increase (Decrease) in Restricted Cash and Investments USD -20.32M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001654954-18-002491
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD -1.24M 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193125-14-310105
us-gaap IncreaseDecreaseInUnearnedPremiums Increase (Decrease) in Unearned Premiums USD -696,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncreaseDecreaseInUnearnedPremiumsNet (Increase) Decrease in Unearned Premiums, Net USD 696,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-04 0001654954-19-012334
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap IncurredClaimsPropertyCasualtyAndLiability Policyholder Benefits and Claims Incurred, Net, Property, Casualty and Liability USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap InsuranceAgencyManagementFee Insurance Agency Management Fee USD 501,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001654954-18-005416
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap InterestPayableCurrent Interest Payable, Current USD 34.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap InvestmentIncomeNet Investment Income, Net USD 8.56M 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 2.00M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031975
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 10.19M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031975
us-gaap Investments Investments USD 11.42M 2022-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009809
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 35,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 6,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 6,000 2020-09-30 2020 Q3 10-Q 2020-11-10 0001654954-20-012114
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 6,000 2024-12-31 2025 Q2 10-Q 2025-08-14 0001641172-25-023960
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 6,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001493152-25-021063
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 39,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 29,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap Liabilities Liabilities USD 871,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 19.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LiabilityForClaimsAndClaimsAdjustmentExpense Liability for Claims and Claims Adjustment Expense USD 91,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability Liability for Claims and Claims Adjustment Expense, Property Casualty Liability USD 0 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year USD 175,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years USD 2.12M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims USD 2.29M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet Liability for Unpaid Claims and Claims Adjustment Expense, Net USD 4.84M 2017-12-31 2017 FY 10-K 2018-03-13 0001654954-18-002491
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-04 0001654954-19-012334
us-gaap LoansPayableCurrent Loans Payable, Current USD 1.00M 2026-03-31 2026 Q1 10-Q 2026-05-11 0001493152-26-022220
us-gaap LoansPayableFairValueDisclosure Loans Payable, Fair Value Disclosure USD 1.00M 2026-03-31 2026 Q1 10-Q 2026-05-11 0001493152-26-022220
us-gaap LongTermInvestments Long-term Investments USD 10.94M 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap LossContingencyLossInPeriod Loss Contingency, Loss in Period USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap MinimumNetCapitalRequiredForEntity1 Minimum Net Capital Required for Entity USD 500 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-196980
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 220,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 1 2021-06-30 2021 Q2 10-Q 2021-08-16 0001654954-21-009072
us-gaap NetCapital Net Capital USD 6.80M 2014-03-31 2014 Q1 10-Q 2014-05-13 0001193125-14-196980
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 12.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -384,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 63,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -646,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001654954-21-005700
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -374,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -67,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001654954-21-005700
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -223,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 164,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap NetIncomeLossAttributableToNonredeemableNoncontrollingInterest Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest USD 14,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001641172-25-009673
us-gaap NetInvestmentIncome Net Investment Income USD 312,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap NotesPayable Notes Payable USD 118,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap NotesPayableCurrent Notes Payable, Current USD 118,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 1.07M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041028
us-gaap OperatingExpenses Operating Expenses USD 1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OperatingLeaseCost Operating Lease, Cost USD 86,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 34,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OperatingLeasePayments Operating Lease, Payments USD 86,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 34,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001654954-20-005483
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 119,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 37,000 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 40,000 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 40,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 6,000 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 73,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.085 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OtherAssetsCurrent Other Assets, Current USD 20,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap OtherInvestments Other Investments USD 48,000 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap OtherLiabilities Other Liabilities USD 1.73M 2024-12-31 2024 FY 10-K 2025-03-26 0001641172-25-000736
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.29M 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041028
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD -1.18M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001493152-25-021063
us-gaap OtherReceivables Other Receivables USD 63,000 2023-12-31 2024 FY 10-K 2025-03-26 0001641172-25-000736
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Portion in Other Comprehensive Loss, Net of Tax, Portion Attributable to Parent, Available-for-sale Securities USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap PaymentsForBrokerageFees Payments for Brokerage Fees USD 116,651 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap PaymentsForLossesAndLossAdjustmentExpense Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid USD 2.29M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap PaymentsForProceedsFromLoansReceivable Payments for (Proceeds from) Loans Receivable USD -141,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-06 0001493152-25-021063
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001654954-19-005905
us-gaap PaymentsOfDividendsCommonStock Payments of Ordinary Dividends, Common Stock USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001654954-19-005905
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesEquity Payments to Acquire Available-for-sale Securities, Equity USD 409,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 1.00M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 2,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap PaymentsToAcquireLoansReceivable Payments to Acquire Loans Receivable USD 100,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 285,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 16,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 2.00M 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap PolicyholderBenefitsAndClaimsIncurredNet Policyholder Benefits and Claims Incurred, Net USD 2.29M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap PolicyLoansReceivable Policy Loans Receivable USD 100,000 2023-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 3.09M 2021-08-11 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap PremiumsEarnedNet Premiums Earned, Net USD 1.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap PremiumsReceivableAllowanceForDoubtfulAccounts Premium Receivable, Allowance for Credit Loss USD 181,000 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap PremiumsReceivableAtCarryingValue Premiums Receivable, Net USD 202,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap PremiumsReceivableGross Premiums Receivable, Gross USD 370,000 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap PremiumsWrittenNet Premiums Written, Net USD -1.46M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001493152-23-041028
us-gaap PreOpeningCosts Pre-Opening Costs USD 145,000 2013-04-04 2013-12-31 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 105,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ProceedsFromCollectionOfLoansReceivable Proceeds from Collection of Loans Receivable USD 141,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030747
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-17 0001654954-16-000181
us-gaap ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital Proceeds from Equity Method Investment, Distribution, Return of Capital USD 8,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-14 0001654954-16-003977
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 29.30M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001193125-15-373935
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 1.47M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-06 0001493152-25-021063
us-gaap ProceedsFromIssuanceOfMediumTermNotes Proceeds from Issuance of Medium-term Notes USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 6.70M 2013-06-01 2013-06-30 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 1.00M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001493152-26-022220
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 63,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 208,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesEquity Proceeds from Sale of Available-for-sale Securities, Equity USD 1.35M 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 73,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ProceedsFromSaleOfLoansReceivable Proceeds from Sale of Loans Receivable USD 141,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 5.00M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001193125-15-373935
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -187,000 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001493152-25-021063
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 146,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 14,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ProvisionForLossOnContracts Provision for Loss on Contracts USD 0 2015-09-30 2015 Q3 10-Q 2015-11-12 0001193125-15-373935
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 35,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 100,000 2023-12-31 2024 FY 10-K 2025-03-26 0001641172-25-000736
us-gaap RecordedThirdPartyEnvironmentalRecoveriesNet Recorded Third-Party Environmental Recoveries, Net USD 177,000 2021-06-30 2021 Q2 10-Q 2021-08-16 0001654954-21-009072
us-gaap ReinsurancePayable Reinsurance Payable USD 73,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ReinsuranceReceivablesPaidLossesRecoverable Reinsurance Receivables (Deprecated 2016-01-31) USD 0 2016-03-31 2016 Q1 10-Q 2016-05-16 0001654954-16-000325
us-gaap ReinsuranceRecoverables Reinsurance Recoverables, Including Reinsurance Premium Paid USD 0 2019-12-31 2019 FY 10-K 2020-03-23 0001654954-20-002991
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001654954-21-005700
us-gaap RelatedPartyTransactionDueFromToRelatedParty Related Party Transaction, Due from (to) Related Party USD 35,000 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap RepaymentsOfDebt Repayments of Debt USD 98,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 600,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001654954-20-012114
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 6.71M 2025-12-31 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 391,000 2024-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030747
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -32.46M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap Revenues Revenues USD 1.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 124,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0001493152-24-030747
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 2.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 1.12M 2013-06-01 2013-06-30 2014 FY 10-K 2015-03-18 0001193125-15-097032
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 9.38 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap SecuritiesHeldAsCollateralAtFairValue Securities Held as Collateral, at Fair Value USD 0 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 198,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-17 0001654954-16-000181
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 60,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 5.86 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 88,626 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 5.86 2018-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 48,626 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-19 0001654954-19-002948
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 1.65 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.9 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 0.35 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001654954-18-002491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 400,000 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 399,688 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.78 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 6 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 35,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 400,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0001493152-23-009809
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 75,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.31 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 44,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 2.25 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 1.05 2023-12-31 2025 Q3 10-Q 2025-11-06 0001493152-25-021063
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0001654954-22-006595
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 416,250 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.37 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 22,500 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001193125-15-288072
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.31 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 6 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.5 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap SharePrice Share Price USD/shares 5.14 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 6 2014-02-28 2015 Q3 10-Q 2015-11-12 0001193125-15-373935
us-gaap ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net USD 69.98M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net USD 59,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet Short-duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net USD 70.07M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net USD 91,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap ShortdurationInsuranceContractsNumberOfReportedClaims Short-duration Insurance Contract, Cumulative Number of Reported Claims pure 5 2016-12-31 2016 FY 10-K 2017-03-13 0001654954-17-001925
us-gaap StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance Statutory Accounting Practices, Statutory Capital and Surplus, Balance USD 775,000 2020-12-31 2020 FY 10-K 2021-03-29 0001654954-21-003408
us-gaap StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired Statutory Accounting Practices, Statutory Capital and Surplus Required USD 500,000 2020-09-30 2020 Q3 10-Q 2020-11-10 0001654954-20-012114
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 6.19M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 6.41M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap StockholdersEquityOtherShares Stockholders' Equity, Other Shares shares 112,841 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 177,159 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 43,750 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-14 0001493152-22-031975
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 290,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 58,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2015-01-01 2015-06-30 2016 Q2 10-Q 2016-08-15 0001654954-16-001599
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 71,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 418,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013603
us-gaap SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Amount USD 680,000 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Cost USD 1.93M 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties, Fair Value USD 680,000 2023-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense Current Year Claims and Claims Adjustment Expense USD 1.07M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-26 0001493152-24-011313
us-gaap SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense Prior Year Claims and Claims Adjustment Expense USD 2.29M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information, Benefit, Claim, Loss and Settlement Expenses USD 158,000 2021-01-01 2021-12-31 2022 FY 10-K 2022-03-30 0001654954-22-004186
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 12.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap UnderwritingIncomeLoss Underwriting Income (Loss) USD 752.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037784
us-gaap UnearnedPremiums Unearned Premiums USD 230,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -20,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 8.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 5.73M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001654954-21-012095
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 8.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001493152-26-050711

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →